Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Intangibles (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Intangibles for 16 consecutive years, with $12.0 million as the latest value for Q1 2025.

  • On a quarterly basis, Intangibles changed 0.0% to $12.0 million in Q1 2025 year-over-year; TTM through Mar 2025 was $12.0 million, a 0.0% change, with the full-year FY2024 number at $12.0 million, up 18.66% from a year prior.
  • Intangibles was $12.0 million for Q1 2025 at Xtant Medical Holdings, roughly flat from $12.0 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $12.0 million in Q1 2024 to a low of $344000.0 in Q4 2022.
  • A 5-year average of $7.0 million and a median of $10.3 million in 2023 define the central range for Intangibles.
  • Peak YoY movement for Intangibles: crashed 49.47% in 2021, then skyrocketed 2831.69% in 2023.
  • Xtant Medical Holdings' Intangibles stood at $400000.0 in 2021, then decreased by 14.0% to $344000.0 in 2022, then surged by 2831.69% to $10.1 million in 2023, then increased by 18.66% to $12.0 million in 2024, then changed by 0.0% to $12.0 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Intangibles are $12.0 million (Q1 2025), $12.0 million (Q4 2024), and $12.0 million (Q2 2024).